| scholarly article | Q13442814 |
| P2093 | author name string | Richard G Fiscella | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | S432-9 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | American Journal of Managed Care | Q15807020 |
| P1476 | title | Understanding dry eye disease: a managed care perspective | |
| P478 | volume | 17 Suppl 16 |
| Q55280295 | A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease. |
| Q34043708 | Androgen deficiency and dry eye syndrome in the aging male |
| Q38712838 | Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye? |
| Q36252489 | Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment |
| Q33686417 | Image-guided evaluation and monitoring of treatment response in patients with dry eye disease |
| Q47093888 | Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome. |
| Q34194231 | Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies |
| Q61811564 | TearCare system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare treatment on subjects with dry eye disease |
Search more.